bisoprolol has been researched along with Angina at Rest in 2 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivanova, LA | 1 |
| Kanorskii, SG | 1 |
| Rostovtseva, ON | 1 |
| Halil Sufian, B | 1 |
| Galenko-Yaroshevskii, PA | 1 |
| Rayo Llerena, I | 1 |
| Marín Huerta, E | 1 |
1 review available for bisoprolol and Angina at Rest
| Article | Year |
|---|---|
[Silent myocardial ischemia. Arguments against treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Bisoprolol; Calcium Channe | 1996 |
1 trial available for bisoprolol and Angina at Rest
| Article | Year |
|---|---|
Treatment of acute coronary syndromes in patients with type 2 diabetes mellitus with beta-adrenoblockers and angiotensin-converting enzyme inhibitors: cardiohemodynamic effects and impact for prognosis.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors | 2004 |